Orbimed Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

A detailed history of Orbimed Advisors LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 45,200 shares of REGN stock, worth $34.2 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
45,200
Previous 22,800 98.25%
Holding current value
$34.2 Million
Previous $24 Million 98.29%
% of portfolio
1.12%
Previous 0.58%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $22.9 Million - $26.9 Million
22,400 Added 98.25%
45,200 $47.5 Million
Q1 2024

May 15, 2024
BUY
$902.69 - $993.35 $8.4 Million - $9.24 Million
9,300 Added 68.89%
22,800 $21.9 Million
Q2 2023

Aug 14, 2023
SELL
$700.03 - $830.35 $7.35 Million - $8.72 Million
-10,500 Reduced 43.75%
13,500 $9.7 Million
Q1 2023

May 15, 2023
BUY
$680.49 - $826.97 $16.3 Million - $19.8 Million
24,000 New
24,000 $19.7 Million
Q2 2022

Aug 15, 2022
BUY
$548.35 - $738.84 $12.2 Million - $16.4 Million
22,200 New
22,200 $13.1 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $7.37 Million - $9.1 Million
-13,560 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $7.78 Million - $9.23 Million
13,560 New
13,560 $8.21 Million
Q3 2020

Nov 16, 2020
SELL
$544.75 - $658.21 $16.8 Million - $20.3 Million
-30,900 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $6.76 Million - $8.82 Million
13,700 Added 79.65%
30,900 $19.3 Million
Q1 2020

May 15, 2020
SELL
$336.18 - $494.43 $64.6 Million - $95 Million
-192,100 Reduced 91.78%
17,200 $8.4 Million
Q4 2019

Feb 14, 2020
SELL
$274.13 - $376.51 $5.15 Million - $7.08 Million
-18,800 Reduced 8.24%
209,300 $78.6 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $3.36 Million - $3.92 Million
12,300 Added 5.7%
228,100 $63.3 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $299,600 - $414,820
1,000 Added 0.47%
215,800 $67.5 Million
Q1 2019

May 15, 2019
SELL
$372.08 - $439.57 $2.72 Million - $3.21 Million
-7,300 Reduced 3.29%
214,800 $88.2 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $57.9 Million - $69.4 Million
-172,300 Reduced 43.69%
222,100 $83 Million
Q3 2018

Nov 14, 2018
BUY
$351.14 - $408.51 $7.69 Million - $8.95 Million
21,900 Added 5.88%
394,400 $159 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $168 Million - $204 Million
-590,400 Reduced 61.31%
372,500 $129 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $34.2 Million - $42.6 Million
108,300 Added 12.67%
962,900 $332 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $101 Million - $132 Million
281,830 Added 49.2%
854,600 $321 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $247 Million - $289 Million
572,770
572,770 $256 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email